Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Enterococcus bacteremia  + (16:24:33, 12 March 2022)
• Streptococcus  + (16:42:24, 12 March 2022)
• CR:DOI:e988b075cb077114b3f7be1c30a2e105  + (16:59:49, 12 March 2022)
• CR:DOI:4f998a83c8e5f34dd6c814a6b14ebcfc  + (22:02:47, 12 March 2022)
• CR:DOI:b5eea92fc03256e3a3891b33ea68ee03  + (22:06:35, 12 March 2022)
• CR:DOI:57b132d01e0b0b10e5ff13b429bedb3c  + (22:09:04, 12 March 2022)
• Herpes simplex pneumonitis  + (22:09:13, 12 March 2022)
• Ornithodorus  + (23:14:10, 12 March 2022)
• Ventilator-associated pneumonia  + (23:16:40, 12 March 2022)
• Ventricular shunt infection  + (23:16:52, 12 March 2022)
• Vertebral osteomyelitis  + (23:17:04, 12 March 2022)
• Waterhouse-Friderichsen syndrome  + (23:17:50, 12 March 2022)
• Yeast and yeast-like organisms  + (23:18:38, 12 March 2022)
• Zoonotic infections  + (23:19:31, 12 March 2022)
• Murmur  + (17:33:11, 15 March 2022)
• Pulsus bisferiens  + (17:39:37, 15 March 2022)
• Tumour necrosis factor-α inhibitors  + (00:40:31, 17 March 2022)
• Adalimumab  + (00:43:19, 17 March 2022)
• Category:TNF-α inhibitors  + (00:43:30, 17 March 2022)
• Category:Monoclonal antibodies  + (00:43:46, 17 March 2022)
• Infliximab  + (00:46:55, 17 March 2022)
• Etanercept  + (00:50:40, 17 March 2022)
• Rheumatoid arthritis  + (00:56:16, 17 March 2022)
• Efalizumab  + (01:05:40, 17 March 2022)
• Alemtuzumab  + (01:11:47, 17 March 2022)

• Abatacept  + (01:16:04, 17 March 2022)

• Category:T-cell costimulation inhibitors  + (01:16:16, 17 March 2022)
• Anakinra  + (01:16:50, 17 March 2022)
• Category:IL-1 inhibitors  + (01:17:01, 17 March 2022)
• Rilonacept  + (01:17:22, 17 March 2022)
• Certolizumab pegol  + (11:12:19, 17 March 2022)
• Alefacept  + (11:15:24, 17 March 2022)
• Rituximab  + (11:18:51, 17 March 2022)
• Tositumomab  + (11:20:23, 17 March 2022)
• Gemtuzumab ozogamicin  + (11:23:19, 17 March 2022)
• Bevacizumab  + (11:26:37, 17 March 2022)
• SCORTEN score  + (21:20:52, 20 March 2022)
• Body surface area  + (21:29:32, 20 March 2022)
• CR:DOI:9e3503306da31f0700db99291beb5a46  + (15:19:11, 22 March 2022)
• Bronchiectasis  + (15:19:24, 22 March 2022)
• Rheumatoid factor  + (10:39:30, 27 March 2022)
• CR:DOI:bae7ec07e96a98c3bcc5253cf11d51a4  + (17:08:00, 29 March 2022)
• Cryptococcus  + (15:02:16, 30 March 2022)
• β-lactam resistance  + (16:10:33, 2 April 2022)
• Wound care  + (18:38:29, 3 April 2022)
• Open joint injury  + (16:16:04, 4 April 2022)
• Renal cell carcinoma  + (16:42:36, 5 April 2022)
• Vibrio  + (14:19:53, 6 April 2022)
• Febrile neutropenia  + (18:56:24, 6 April 2022)
• Endophthalmitis  + (19:27:11, 7 April 2022)
• Intravenous immune globulin  + (19:04:45, 8 April 2022)